Adenoid cystic carcinoma (ACC) is a rare epithelial malignancy arising from secretory glands, particularly the salivary glands. It tends to invade nerves and has a high potential for distant hematogenous metastasis, especially to the lungs, bone, liver and brain. The breast and hypophysis are not common sites of ACC metastatic disease. Herein, we report a case of ACC of the head and neck region with two unusual sites of metastases, the hypophysis and breast. Keywords: PET/CT, adenoid cystic carcinoma, breast, hypophysis, metastasis
. A 49-year-old woman presented with a left cervical mass. The ultrasound examination revealed a gross mass adjacent to the thyroid gland and she underwent total excision of the mass along with total thyroidectomy. Histopathologic examination of the 9.5x10 cm mass revealed adenoid cystic carcinoma (ACC) infiltrating both the thyroid and adjacent smooth muscle tissue. (A, B): Hematoxylin and eosin (H&E) staining of the primary tumor: Tumor cells were arranged in cord-like or acinar-like by atypical hyperplastic epithelial cells forming a cribriform and tubular pattern with a mucoid luminal material (x40). (C, D): Tumor cells were negative for thyroglobulin (C) and TTF-1 (D) excluding thyroid origin (x40). Tumor cells were immune-positive for CD-117 (E) indicating ductal origin and E-cadherin (F) (x100). She was accepted as ACC of the head and neck region. The patient was referred to FDG PET/CT scanning for initial staging. PET/CT images revealed multiple hypermetabolic lung metastasis and a mild FDG uptake in the operation region secondary to surgery. She received radiotherapy and chemotherapy, and was stable for about 20 months follow-up There was also a smaller non-metabolic lesion next to this lesion. The patient underwent incisional biopsy, the histopathologic examination revealed ACC in the lateral lesion while the other one was composed of necrotic material. The histology and immunophenotyping of the breast ACC is similar to that of the salivary gland. Therefore, it is difficult to differentiate metastatic disease from a primary breast ACC by pathologic examination. The diagnosis is usually based on clinical behavior of the tumor. In our case, based on the clinical findings (sudden onset in one year), it was diagnosed as metastasis from the primary tumor. Hypermetabolic right parasternal, anterior diaphragmatic/paracardiac lymph nodes were also detected in the same examination. (G, H, I ): In the following FDG PET/CT, her metastatic breast lesion progressed anatomically (24x35 mm) while remaining metabolically stable (SUV max : 5.6). Anterior mediastinal, paracardiac, parasternal and right anterior mediastinal lymph nodes were also detected as new findings while the existing lung metastasis were progressing. (D, G): The patient also had multiple hypodense stable lesions in the liver that did not show any FDG uptake, compatible with hemangiomas. The patient's chemoradiotherapy is still on-going in the third year of diagnosis. In the consecutive follow-up PET/CT images performed at 4 month intervals, her metastatic lung lesions, lymph nodes and breast lesion all have been progressing both in dimension and metabolically. Breast metastasis from extra-mammary neoplasms is very rare, with a reported incidence of 0.5-3% (6). Also, the incidence of unexpected breast focal uptake in 18 F-DG-PET/CT is reported as 0.36-1.12% (7, 8, 9) . The rate of malignancy in incidental FDG-avid breast foci was reported in a range of 37.5-83% (10, 11, 12) . Under these circumstances, it can be concluded that focal FDG-avid breast lesions need further evaluation, especially in cases with known malignancies
